D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 43 Citations 9,096 136 World Ranking 3015 National Ranking 60

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • DNA
  • Immune system

Lu Lu spends much of his time researching Virology, Coronavirus, Lipid bilayer fusion, Middle East respiratory syndrome coronavirus and Virus. His Virology research is multidisciplinary, relying on both Immunology and Monoclonal antibody. In his research, Coronavirus Infections is intimately related to Pandemic, which falls under the overarching field of Coronavirus.

His work in Lipid bilayer fusion addresses issues such as Viral replication, which are connected to fields such as Plasma protein binding and Gp41. His work on Titer as part of general Virus research is frequently linked to Virulence and Genomic signature, thereby connecting diverse disciplines of science. His study in Viral protein is interdisciplinary in nature, drawing from both Inhibitory postsynaptic potential, Structural biology, Plasma membrane fusion, Protein structure and Peptide.

His most cited work include:

  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. (672 citations)
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. (477 citations)
  • Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (416 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Virology, Gp41, Virus, Peptide and Biochemistry. As part of the same scientific family, Lu Lu usually focuses on Virology, concentrating on Antibody and intersecting with Antigen. His Gp41 study combines topics in areas such as Molecular biology, Heptad repeat, Viral envelope and Lipid bilayer fusion.

His research in Peptide intersects with topics in Protein structure, Cell culture, Potency and Fusion inhibitor. Lu Lu has included themes like Sexual transmission and Fusion protein in his Biochemistry study. His work carried out in the field of Coronavirus brings together such families of science as Pandemic and Severe acute respiratory syndrome coronavirus 2.

He most often published in these fields:

  • Virology (50.00%)
  • Gp41 (29.44%)
  • Virus (19.35%)

What were the highlights of his more recent work (between 2019-2021)?

  • Virology (50.00%)
  • Severe acute respiratory syndrome coronavirus 2 (6.45%)
  • Coronavirus (12.50%)

In recent papers he was focusing on the following fields of study:

Lu Lu mainly investigates Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus, Antibody and Cancer research. His Virology research incorporates elements of Peptide and Antigen. The Coronavirus study which covers Betacoronavirus that intersects with Pandemic.

His work on Epitope, Monoclonal antibody and Neutralizing antibody as part of general Antibody study is frequently linked to Protein domain, therefore connecting diverse disciplines of science. His Cancer research research includes themes of Cancer cell, LNCaP, Receptor and Metastasis. His studies deal with areas such as Cell culture and Enfuvirtide as well as Virus.

Between 2019 and 2021, his most popular works were:

  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. (672 citations)
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. (477 citations)
  • Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (416 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • DNA
  • Internal medicine

His main research concerns Virology, Severe acute respiratory syndrome coronavirus 2, Spike Protein, Lipid bilayer fusion and Coronavirus. The Virology study combines topics in areas such as Cytokine, Immune disorder, Decoy, Proinflammatory cytokine and Lung injury. Lu Lu integrates many fields, such as Spike Protein and engineering, in his works.

His study looks at the intersection of Binding site and topics like Antibody with Peptide library. In general Lipid bilayer fusion study, his work on Plasma membrane fusion often relates to the realm of Protein subunit, thereby connecting several areas of interest. His Coronavirus research focuses on Betacoronavirus and how it relates to Coronavirus Infections.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

Xiaolong Tian;Cheng Li;Ailing Huang;Shuai Xia.
Emerging microbes & infections (2020)

842 Citations

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu.
Cell Research (2020)

745 Citations

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Wu F;Wang A;Liu M;Wang Q.
Social Science Research Network (2020)

498 Citations

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

Lu Lu;Qi. Liu;Yun Zhu;Kwok-Hung Chan.
Nature Communications (2014)

347 Citations

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.

Shuai Xia;Yun Zhu;Meiqin Liu;Qiaoshuai Lan.
Cellular & Molecular Immunology (2020)

286 Citations

SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion

Xinling Wang;Wei Xu;Gaowei Hu;Shuai Xia.
Cellular & Molecular Immunology (2020)

268 Citations

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

Lanying Du;Guangyu Zhao;Zhihua Kou;Cuiqing Ma.
Journal of Virology (2013)

227 Citations

Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies

Tianlei Ying;Lanying Du;Tina W. Ju;Ponraj Prabakaran.
Journal of Virology (2014)

221 Citations

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

Shuai Xia;Lei Yan;Wei Xu;Anurodh Shankar Agrawal.
Science Advances (2019)

213 Citations

MERS-CoV spike protein: a key target for antivirals

Lanying Du;Yang Yang;Yusen Zhou;Lu Lu.
Expert Opinion on Therapeutic Targets (2017)

189 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lu Lu

Shibo Jiang

Shibo Jiang

Fudan University

Publications: 145

Lanying Du

Lanying Du

New York Blood Center

Publications: 52

Shuwen Liu

Shuwen Liu

Southern Medical University

Publications: 41

Kwok-Yung Yuen

Kwok-Yung Yuen

University of Hong Kong

Publications: 38

Yusen Zhou

Yusen Zhou

Zhengzhou University

Publications: 29

Ralph S. Baric

Ralph S. Baric

University of North Carolina at Chapel Hill

Publications: 28

Jasper F. W. Chan

Jasper F. W. Chan

University of Hong Kong

Publications: 27

Jesse D. Bloom

Jesse D. Bloom

Fred Hutchinson Cancer Research Center

Publications: 25

Ian A. Wilson

Ian A. Wilson

Scripps Research Institute

Publications: 23

Chien Te K. Tseng

Chien Te K. Tseng

The University of Texas Medical Branch at Galveston

Publications: 22

Yuxian He

Yuxian He

Peking Union Medical College Hospital

Publications: 21

Paul D. Bieniasz

Paul D. Bieniasz

Rockefeller University

Publications: 21

George F. Gao

George F. Gao

Chinese Center For Disease Control and Prevention

Publications: 21

Dimiter S. Dimitrov

Dimiter S. Dimitrov

University of Pittsburgh

Publications: 20

Kelvin K. W. To

Kelvin K. W. To

University of Hong Kong

Publications: 19

Michel C. Nussenzweig

Michel C. Nussenzweig

Rockefeller University

Publications: 19

Trending Scientists

Calvin R. Maurer

Calvin R. Maurer

Stanford University

Shusheng Zhang

Shusheng Zhang

Qingdao University of Science and Technology

Irwin C. Gunsalus

Irwin C. Gunsalus

University of Illinois at Urbana-Champaign

Sander G. Mills

Sander G. Mills

MSD (United States)

Daniel B. Miracle

Daniel B. Miracle

United States Air Force Research Laboratory

Peter C. Eklund

Peter C. Eklund

Pennsylvania State University

Stephen E. Halford

Stephen E. Halford

University of Bristol

Jaan Liira

Jaan Liira

University of Tartu

Takeji Nishikawa

Takeji Nishikawa

Keio University

Bradley A. Carlson

Bradley A. Carlson

National Institutes of Health

Yasuo Mori

Yasuo Mori

Kyoto University

Cristina Limatola

Cristina Limatola

Sapienza University of Rome

Joseph R. Fetcho

Joseph R. Fetcho

Cornell University

Jürgen Debus

Jürgen Debus

University Hospital Heidelberg

Julia Hippisley-Cox

Julia Hippisley-Cox

University of Oxford

Linda-Gail Bekker

Linda-Gail Bekker

University of Cape Town

Something went wrong. Please try again later.